News
Eli Lilly's experimental pill worked as well as blockbuster drug Ozempic to lower weight and blood sugar in a trial of ...
Bagsværd, Denmark, 29 March 2025 – Novo Nordisk today presented the full results from STRIDE, a phase 3b peripheral artery disease (PAD) outcomes trial investigating the effects of once-weekly ...
In studies of Ozempic for type 2 diabetes, 20.3% of participants taking a 1-milligram (mg) dose of Ozempic reported feeling nauseous, compared to 6.1% of those given a placebo. Higher doses are ...
its phase 3b trial investigating the effects of once-weekly Ozempic ® (semaglutide) injection 1 mg in adults with type 2 diabetes and early-stage symptomatic PAD 1, at the American College of ...
PLAINSBORO, N.J., April 14, 2025 /PRNewswire/ -- Novo Nordisk has become aware of several hundred units of Ozempic® (semaglutide) injection 1 mg distributed outside the Novo Nordisk authorized ...
FDA was notified by Novo Nordisk on April 3 that several hundred units of counterfeit Ozempic (semaglutide) injection 1 mg were in the U.S. drug supply chain. (FDA) Get top local stories in San ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results